Stephen Brozak
Stock Analyst at WBB Securities
(0.49)
# 2045
Out of 5,218 analysts
15
Total ratings
100.00%
Success rate
-87.46%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cidara Therapeutics | Maintains: Strong Buy | 40 45 | 23.25 | 93.55% | 6 | Dec 5, 2024 | |
Arcturus Therapeutic... | Downgrades: Hold | 31 | 17.2 | 80.23% | 2 | Jun 9, 2020 | |
Paratek Pharmaceutic... | Initiates Coverage On: Speculative Buy | 6 | n/a | n/a | 1 | Jan 8, 2020 | |
TapImmune | Upgrades: Buy | 5 0 | n/a | n/a | 2 | May 30, 2018 | |
Alcobra Ltd. - Ordin... | Upgrades: Speculative Buy | 14 | n/a | n/a | 4 | Oct 9, 2017 |